Ovid Therapeutics Inc.OVIDNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank82
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P82
Within normal range
vs 2Y Ago
10.1x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202534.12%
202449.50%
20233.38%
2022-144.10%
2021251.58%
2020-34.03%
2019-16.32%
201819.79%
2017-189.13%
2016-70.32%